Open Access Repository

Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis

Singh, A ORCID: 0000-0002-4618-7507, Hussain, S and Antony, B ORCID: 0000-0001-8704-6084 2021 , 'Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis' , Diabetes & Metabolic Syndrome, vol. 15, no. 3 , pp. 813-822 , doi: 10.1016/j.dsx.2021.03.019.

Full text not available from this repository.

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) patients represent a vulnerable population that may be susceptible to more severe COVID-19. Moreover, not only the underlying NAFLD may influence the progression of COVID-19, but the COVID-19 may affect the clinical course of NAFLD as well. However, comprehensive evidence on clinical outcomes in patients with NAFLD is not well characterized.Objectives: To systematically review and meta-analysis the evidence on clinical outcomes in NAFLD patients with COVID-19.Methods: MEDLINE, EMBASE, and Cochrane Central were searched from inception through November 2020. Epidemiological studies assessing the clinical outcomes in COVID-19 patients with NAFLD were included. Newcastle-Ottawa Scale (NOS) was used to assess study quality. Generic inverse variance method using RevMan was used to determine the pooled estimates using the random-effects model.Results: Fourteen studies consisting of 1851 NAFLD patients, were included. Significant heterogeneity was observed among the studies, and studies were of moderate to high quality [mean, (range):8 (6, 8)]. For NAFLD patients, the adjusted odds ratio (aOR) for the severe COVID-19 was 2.60 (95%CI:2.24-3.02; p Conclusions: An increased risk of severe COVID-19 infection and admission to ICU due to COVID-19 with no difference in mortality was observed between NAFLD and non-NAFLD patients. Future studies should include the mortality outcome to conclusively elucidate the impact of NAFLD in patients with COVID-19.

Item Type: Article
Authors/Creators:Singh, A and Hussain, S and Antony, B
Keywords: NAFLD,COVID-19, mortality, severity, systematic review
Journal or Publication Title: Diabetes & Metabolic Syndrome
Publisher: Elsevier Ltd.
ISSN: 1871-4021
DOI / ID Number: 10.1016/j.dsx.2021.03.019
Copyright Information:

Copyright 2021 Diabetes India

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP